Publication | Closed Access
BRCA1 is a 220-kDa nuclear phosphoprotein that is expressed and phosphorylated in a cell cycle-dependent manner.
268
Citations
0
References
1996
Year
GeneticsImmunologyBaculovirus-derived Brca1Molecular GeneticsCell CycleCell Cycle-dependent MannerCancer BiologyTumor BiologyCancer-associated VirusCell RegulationCell SignalingBrca1 ExpressionCell Division220-Kda Nuclear PhosphoproteinCell BiologyProtein PhosphorylationSignal TransductionHuman Brca1 ProteinCellular BiochemistryMedicineViral Oncology
Mouse polyclonal antibodies, raised against three regions of the human BRCA1 protein, were characterized and revealed BRCA1 as a 220-kDa nuclear phosphoprotein in normal cells. All three antisera recognize both in vitro-translated and recombinant, baculovirus-derived BRCA1, which co-migrate with BRCA1 from the human breast epithelia cell line, HBL100. BRCA1 expression and phosphorylation are shown to be cell cycle dependent, with greatest expression and phosphorylation occurring in S and M phases. Cyclin-dependent kinase 2 and other kinases associated with cyclins D and A are shown to bind to and phosphorylate BRCA1, suggesting that the biological activity of BRCA1 may be regulated by cyclin-dependent kinases.